Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Maes

Showing results (41-50 of 723) with videos related to

Pageof 73
Sort By:
Current Neuropharmacology|March 27, 2014
Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the AmygdalaGeorge Anderson, Michael Maes
CNS Spectrums|April 12, 2021
In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of lifeMichael Maes, Buranee Kanchanatawan
Medical Hypotheses|September 7, 2012
Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS)Gerwyn Morris, Michael Maes
CNS & Neurological Disorders Drug Targets|July 12, 2014
Local melatonin regulates inflammation resolution: a common factor in neurodegenerative, psychiatric and systemic inflammatory disordersGeorge Anderson, Michael Maes
Neuro Endocrinology Letters|May 21, 2013
Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue Syndrome: from clinical-consensus to evidence-based case definitionsGerwyn Morris, Michael Maes
Neuro Endocrinology Letters|February 14, 2014
Molecular mechanisms underpinning laser printer and photocopier induced symptoms, including chronic fatigue syndrome and respiratory tract hyperresponsiveness: pharmacological treatment with cinnamon and hydrogenKurt Lucas, Michael Maes
BMC Medicine|November 16, 2013
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsGerwyn Morris, Michael Maes
Advances in Experimental Medicine and Biology|April 9, 2021
From "Leaky Gut" to Impaired Glia-Neuron Communication in DepressionLeszek Rudzki, Michael Maes
Current Pharmaceutical Design|August 10, 2020
Role of Opioidergic System in Regulating Depression PathophysiologyGeorge Anderson, Michael Maes
Molecular Neurobiology|July 24, 2020
The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major DepressionLeszek Rudzki, Michael Maes
Pageof 73

Showing results (41-50 of 723) with videos related to

Sort By:
Pageof 73
Current Neuropharmacology|March 27, 2014
Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the AmygdalaGeorge Anderson, Michael Maes
CNS Spectrums|April 12, 2021
In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of lifeMichael Maes, Buranee Kanchanatawan
Medical Hypotheses|September 7, 2012
Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS)Gerwyn Morris, Michael Maes
CNS & Neurological Disorders Drug Targets|July 12, 2014
Local melatonin regulates inflammation resolution: a common factor in neurodegenerative, psychiatric and systemic inflammatory disordersGeorge Anderson, Michael Maes
Neuro Endocrinology Letters|May 21, 2013
Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue Syndrome: from clinical-consensus to evidence-based case definitionsGerwyn Morris, Michael Maes
Neuro Endocrinology Letters|February 14, 2014
Molecular mechanisms underpinning laser printer and photocopier induced symptoms, including chronic fatigue syndrome and respiratory tract hyperresponsiveness: pharmacological treatment with cinnamon and hydrogenKurt Lucas, Michael Maes
BMC Medicine|November 16, 2013
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsGerwyn Morris, Michael Maes
Advances in Experimental Medicine and Biology|April 9, 2021
From "Leaky Gut" to Impaired Glia-Neuron Communication in DepressionLeszek Rudzki, Michael Maes
Current Pharmaceutical Design|August 10, 2020
Role of Opioidergic System in Regulating Depression PathophysiologyGeorge Anderson, Michael Maes
Molecular Neurobiology|July 24, 2020
The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major DepressionLeszek Rudzki, Michael Maes
Pageof 73